MBD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.969100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.270110E-02
Normal-vs-Stage2
1.178730E-03
Normal-vs-Stage3
2.690100E-02
Normal-vs-Stage4
7.654400E-02
Stage1-vs-Stage2
2.050600E-01
Stage1-vs-Stage3
7.893000E-01
Stage1-vs-Stage4
6.142200E-01
Stage2-vs-Stage3
1.781970E-01
Stage2-vs-Stage4
7.045000E-01
Stage3-vs-Stage4
5.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.621400E-04
Normal-vs-AfricanAmerican
2.536500E-02
Normal-vs-Asian
2.916800E-03
Caucasian-vs-AfricanAmerican
6.732800E-01
Caucasian-vs-Asian
2.531200E-01
AfricanAmerican-vs-Asian
2.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.190200E-04
Normal-vs-Female
3.738100E-03
Male-vs-Female
5.455700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.613500E-02
Normal-vs-Age(41-60Yrs)
3.677200E-03
Normal-vs-Age(61-80Yrs)
5.244300E-04
Normal-vs-Age(81-100Yrs)
5.159000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.648200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.887210E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.074500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.289810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.077600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.557000E-04
Normal-vs-Daily Drinker
1.104020E-03
Normal-vs-Weekly Drinker
1.179790E-02
Normal-vs-Occasional Drinker
1.022010E-02
Normal-vs-Social Drinker
3.441400E-03
Non Drinker-vs-Daily Drinker
9.118200E-01
Non Drinker-vs-Weekly Drinker
4.643600E-01
Non Drinker-vs-Occasional Drinker
1.448440E-01
Non Drinker-vs-Social Drinker
1.347200E-01
Daily Drinker-vs-Weekly Drinker
5.412000E-01
Daily Drinker-vs-Occasional Drinker
1.966840E-01
Daily Drinker-vs-Social Drinker
1.739030E-01
Weekly Drinker-vs-Occasional Drinker
6.038600E-01
Weekly Drinker-vs-Social Drinker
5.769200E-01
Occasional Drinker-vs-Social Drinker
9.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.836200E-01
Normal-vs-Grade 2
8.977200E-01
Normal-vs-Grade 3
8.958600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.456200E-02
Grade 1-vs-Grade 3
9.950200E-02
Grade 1-vs-Grade 4
9.836200E-01
Grade 2-vs-Grade 3
9.594000E-01
Grade 2-vs-Grade 4
8.977200E-01
Grade 3-vs-Grade 4
8.958600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.378100E-04
Normal-vs-NonDiabetic
6.233400E-04
Diabetic-vs-NonDiabetic
7.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.155120E-03
Normal-vs-NoPancreatitis
6.804200E-04
Pancreatitis-vs-NoPancreatitis
7.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.364590E-03
Normal-vs-N1
1.000470E-03
N0-vs-N1
3.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.695900E-02
Normal-vs-TP53-NonMutant
7.097800E-03
TP53-Mutant-vs-TP53-NonMutant
8.734200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
